Skip to main content
. 2021 Jan 19;12:100207. doi: 10.1016/j.bbih.2021.100207

Table 1.

Baseline characteristics of critically ill neurologic patients in 2020 vs. 2019.

Variable
During COVID-19 Pandemic (01/20/20 to 06/15/20)
Before Pandemic (01/20/19 to 06/15/19)
% Decrease in 2020 vs. 2019 p-value
A. Disease: (ICD-10 Code) No. of patients No. of COVID-19 patients (%) No. of patients
Subarachnoid Hemorrhage: (I60) 1165 ≤10 1598 27.1% <0.0001
Intracerebral Hemorrhage: (I61) 1886 17 (0.9%) 2529 25.4% <0.0001
Ischemic Stroke: (I63) 4556 77 (1.7%) 6440 29.6% <0.0001
Status epilepticus (G40.901) 817 ≤10 1204 32.1% <0.0001
Traumatic Brain Injury: (S06) 2737 25 (0.9%) 3621 24.4% <0.0001
Neuromuscular emergencies (MGa G70.01+ GBSb G61.0) 106 ≤10 205 48.3% <0.0001
All patients 8568d 118 (1.4%) 11,917d 28.1% <0.0001
B. Demographics 01/20/20 to 06/15/20 01/20/19 to 06/15/19
Age (yrs) 58.8 ​± ​21.2 58.5 ​± ​21.2
Female sex n (%) 3741 (44%) 5304 (45%)
White n (%) 5675 (66%) 8116 (68%)
Black n (%) 2019 (24%) 2602 (22%)
Asian n (%) 154 (2%) 186 (2%)
Hispanic ethnicity n (%)
633 (7%)
1072 (9%)
C. Co-morbidities
01/20/20 to 06/15/20
01/20/19 to 06/15/19
p-value
Hypertension n (%) 4305 (50.3%) 6038 (50.7%) 0.55
Ischemic heart disease n (%) 2182 (25.5%) 3177 (26.7%) 0.06
Diabetes Mellitus n (%) 2127 (24.8%) 2961 (24.9%) 0.97
Heart Failure n (%) 1715 (20.0%) 2440 (20.5%) 0.42
Chronic Kidney Disease n (%) 1565 (18.3%) 2110 (17.7%) 0.30
Nicotine dependence n (%) 1460 (17.0%) 2018 (16.9%) 0.84
Atrial Fibrillation n (%) 1441 (16.8%) 2094 (17.6%) 0.16
Obesity n (%) 1367 (16.0%) 1966 (16.5%) 0.30
COPDc n (%) 1012 (11.8%) 1437 (12.1%) 0.59
Asthma n (%) 694 (8.1%) 986 (8.3%) 0.65
a

MG: Myasthenia gravis with crisis.

b

GBS: Guillian Barre syndrome.

c

COPD: Chronic Obstructive Pulmonary Disease.

d

Total number of patients is lower than the sum of each individual diagnosis because there are some patients with two simultaneous diagnoses, e.g. status epilepticus in patients with intracerebral hemorrhage.